Posted: November 25th, 2022
Pharmathen Global B.V. v. Novartis A.G., Court of Appeal The Hague, The Netherlands, 15 November 2022, Case no. ECLI:NL:GHDHA:2022:2327 Novartis is the holder of – inter alia – European patent EP 2 377 519 B1 entitled ‘Pharmaceutical Composition Comprising Octreotide Microparticles’ Novartis markets an injectable Long Acting Release (hereinafter also: ‘LAR’) product containing octreotide under […]
READ MORE
Posted: November 24th, 2022
It is with great sadness that the EPLAW Board heard of the passing of our long-time member and colleague Gregor Grant after a long illness. Gregor was known to many among the patent community across Europe and will be much missed. His funeral will take place on Thursday, 1st December in London. Further details regarding […]
READ MORE
Posted: November 24th, 2022
The EPO announced that it has published a new trilogy of EPO webinars that outline the Unified Patent Court’s structure and procedures, as well as the timeline for its introduction. Recorded earlier this year in English, the webinars feature UPC experts Kevin Mooney, Klaus Grabinski and Pierre Véron. The webinars and lots of other information […]
READ MORE
Posted: November 15th, 2022
The UJUB (Union for the Unified Patent Court) will hold its 4th mock trial in Paris on Monday 21 November 2022 from 1:00 pm to 6:00 pm CET This 4th mock trial will take place in the International courtroom of the Paris Commercial Court (which will host the hearings of the Central Division of the […]
READ MORE
Posted: November 8th, 2022
LÉKUÉ, S.L. v. PENINSULA 2000, S.A., Barcelona Court of Appeals, Section 15, 30 March 2022 The Barcelona Court of Appeals, by reversing a first-instance Judgment, found that LÉKUÉ’s patent protecting a food container for use in microwave cooking was being infringed by the defendant, PENINSULA 2000. The Court of Appeals criticized the first-instance Court for […]
READ MORE
Posted: November 7th, 2022
Implementation of the SPC manufacturing waiver into Norwegian law, by Guro Nybø, Nora Bratheim, Lars Erik Steinkjer and Gunnar Meyer, Wikborg Rein The SPC manufacturing waiver was adopted by the European Parliament in 2019 through Regulation 2019/933 amending Regulation (EC) no 469/2009 concerning the supplementary protection certificate for medicinal products (the SPC Regulation). The waiver […]
READ MORE
Posted: November 1st, 2022
Novartis AG v. Mylan B.V. and Mylan Ireland Limited, Court of Appeal The Hague, The Netherlands, 18 October 2022, Case no. ECLI:NL:GHDHA:2022:2079 The Novartis-group produces and markets amongst others a medical substance with fingolimod (also named FTY720) as active ingredient for the treatment of relapsing-remitting multiple sclerose (hereafter: RRMS). Novartis holds related EP 2 959 […]
READ MORE
Posted: October 18th, 2022
G 2/21 on post-published evidence and plausibility – Preliminary Opinion of the EBA, reported by Dr. Klaus Reindl and Dr. Georg Anetsberger, Bardehle Pagenberg With the decision T 116/18, three questions were referred to the Enlarged Board of Appeal (EBA) of the EPO relating to post-published evidence. The EBA now issued its preliminary opinion as […]
READ MORE
Posted: October 17th, 2022
Geofabrics lays the tracks for large-scale damages inquiries in the UK Geofabrics Limited v Fiberweb Geosynthetics Limited [2022] EWHC 2363 (Pat) Geofabrics Limited (“Geofabrics”) has been awarded £13.4 million in damages for patent infringement, concluding a 5 year long dispute with Fiberweb Geosynthetics Limited (“Fiberweb”). Damages inquiries are rare in the UK so this judgment […]
READ MORE
Posted: October 13th, 2022
Will the German automatic injunction live forever? By Tobias Wüttke, Meissner Bolte The Regional Court Düsseldorf clarifies in a milestone decision (docket no. 4c O 18/21 of 7 July 2022) that the new proportionality defense pursuant § 139 (1) clause 3 of the revised German Patent Act is not available for unwilling licensees. A. The […]
READ MORE
EMAIL US
